The Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved Leqembi (lecanemab) an Alzheimer’s treatment – where 4.09% of those over 60...
Early trial results give hope for a new potential dyskinesia treatment for people with Parkinson’s disease. A new clinical trial, carried out by Neurolixis and made...
The US Food and Drug Administration (FDA) has approved lecanemab – a breakthrough drug for patients in the earliest stages of Alzheimer’s disease. Developed by Japanese...
